Evol Science LLC has a total of 18 patent applications. It decreased the IP activity by 14.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and electrical machinery and energy are BEIJING HANDIAN PHARMACEUTICAL CO LTD, ANDRX CORP and HUNAN ANBANG PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | United States | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Electrical machinery and energy | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes | |
#6 | Electric discharge tubes |
# | Name | Total Patents |
---|---|---|
#1 | Bhattacharjee Vikram | 16 |
#2 | Andrews Andrew J | 10 |
Publication | Filing date | Title |
---|---|---|
WO2020112627A1 | Combinations of parp inhibitors and mapk activators to treat cancer | |
CA3072181A1 | Combinations to treat cancer | |
WO2017136741A1 | Combinations to treat cancer | |
US2015355190A1 | Compositions and Methods of Analysis |